Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer–specific Mortality: Competition Between Age and Time to Biochemical Failure

Tendulkar, 2016, Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy, J Clin Oncol, 34, 3648, 10.1200/JCO.2016.67.9647 Evans, 2016, Recurrence patterns of oligometastatic disease detected using C-11 choline positron emission tomography/computed tomography in patients with a rising prostate-specific antigen level following postprostatectomy radiation therapy, In J Radiat Oncol, 96, S103, 10.1016/j.ijrobp.2016.06.255 Swanson, 2007, Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794, J Clin Oncol, 25, 2225, 10.1200/JCO.2006.09.6495 Brockman, 2015, Nomogram predicting prostate cancer–specific mortality for men with biochemical recurrence after radical prostatectomy, Eur Urol, 67, 1160, 10.1016/j.eururo.2014.09.019 Dell’Oglio, 2016, Predicting survival of men with recurrent prostate cancer after radical prostatectomy, Eur J Cancer, 54, 27, 10.1016/j.ejca.2015.11.004 Brassell, 2011, Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes, J Urol, 185, 132, 10.1016/j.juro.2010.09.014 Scosyrev, 2012, Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality, Cancer, 118, 3062, 10.1002/cncr.26392 Stish, 2016, Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer, J Clin Oncol, 34, 3864, 10.1200/JCO.2016.68.3425 Abugharib, 2017, Very early salvage radiotherapy improves distant metastasis-free survival, J Urol, 197, 662, 10.1016/j.juro.2016.08.106 Jackson, 2017, Anatomic patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study, BJU Int, 120, 351, 10.1111/bju.13792 Polkinghorn, 2013, Androgen receptor signaling regulates DNA repair in prostate cancers, Cancer Discov, 3, 1245, 10.1158/2159-8290.CD-13-0172 Spratt, 2015, Androgen receptor upregulation mediates radioresistance after ionizing radiation, Cancer Res, 75, 4688, 10.1158/0008-5472.CAN-15-0892 Huggins, 1967, Endocrine-induced regression of cancers, Cancer Res, 27, 1925 Eisenberger, 1998, Bilateral orchiectomy with or without flutamide for metastatic prostate cancer, N Engl J Med, 339, 1036, 10.1056/NEJM199810083391504 Prostate Cancer Trialists’ Collaborative Group, 2000, Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, Lancet, 355, 1491, 10.1016/S0140-6736(00)02163-2 Feldman, 2001, The development of androgen-independent prostate cancer, Nat Rev Cancer, 1, 34, 10.1038/35094009 Shipley, 2016, NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA, J Clin Oncol, 34, 3, 10.1200/jco.2016.34.2_suppl.3 Carrie, 2016, Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial, Lancet Oncol, 17, 747, 10.1016/S1470-2045(16)00111-X Shipley, 2017, Radiation with or without antiandrogen therapy in recurrent prostate cancer, N Engl J Med, 376, 417, 10.1056/NEJMoa1607529 Johnson, 2014, A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy, Pract Radiat Oncol, 4, 422, 10.1016/j.prro.2014.02.003 Spratt, 2017, Individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease, J Clin Oncol, 35, 1991, 10.1200/JCO.2016.70.2811 Zhao, 2016, Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis, Lancet Oncol, 17, 1612, 10.1016/S1470-2045(16)30491-0 Spratt, 2018, Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer, J Clin Oncol, 36, 581, 10.1200/JCO.2017.74.2940 Thorstenson, 2017, Cancer specific mortality in men diagnosed with prostate cancer before age 50 years: a nationwide population based study, J Urol, 197, 61, 10.1016/j.juro.2016.06.080 Lin, 2009, Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study, Cancer, 115, 2863, 10.1002/cncr.24324 Hamdy, 2016, 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220 Brajtbord, 2017, The CAPRA score at 10 years: contemporary perspectives and analysis of supporting studies, Eur Urol, 71, 705, 10.1016/j.eururo.2016.08.065 Zhao, 2015, High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer, Prostate Cancer Prostat Dis, 18, 229, 10.1038/pcan.2015.22 Stephenson, 2006, Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy, J Natl Cancer Inst, 98, 715, 10.1093/jnci/djj190 Spratt, 2018, A systematic review and framework for the use of hormone therapy with salvage radiation therapy for recurrent prostate cancer, Eur Urol, 73, 156, 10.1016/j.eururo.2017.06.027